Igenica Biotherapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Igenica Biotherapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AML (NCT02040506) | Igenica Biotherapeutics, Inc. | 2014-02-01 |
Track Igenica Biotherapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.